Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 0.6% Lugol's solution
Total 0 results
Nothing found
Sponsors and Collaborators
Bruno Rhiner
Department of Emergency Medicine, The First People's Hospital of Hangzhou, Hangzhou, China.
Yu-Hsiang Wu
LM Farma Indústria e Comércio Ltda.
E. Steve Woodle
Nottingham University Hospitals NHS Trust
Eyal Ashkenazi
Camilla Wistrand
STAG1 Gene Foundation
Ministère de la Santé et l'Hygiène Publique, Mali
BiondVax Pharmaceuticals ltd.
GenVivo, Inc.
Virginia G. Kaklamani
Vituity Psychiatry
OLVG, Amsterdam, the Netherlands
Medical College Trivandrum
AtheroNova Inc.
Katarzyna Jórasz
Asahi Kasei Medical Co., Ltd.
MITO
View Full List
Medical Conditions
Any Injury or Illness Acutely Impacting Work
Autism or Autistic Traits
Stage IVA Lymphoepithelioma of the Oropharynx
Rotator Cuff Lesion
HPV-Related Anal Intraepithelial Neoplasia
Imaging, Diagnostic
Intensive Care Neuropathy
Soft Tissue Sarcoma, Adult, Stage II
Symptoms
Child Physical Activity
Phenoxymethylpenicillin
Nondepolarising Muscle Relaxants
NR3C2
Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)
Learning Disturbance
Synbiotics
Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))
Mast-Cell Sarcoma
Cervical Cancer Stage IA2
Serum Bank
View Full List
Drug Interventions
Rituximab plus CHOP
Exendin 9-39
Interleukin-2
Apremilast
Transdermal estradiol
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
Thiotepa
FHND5071
Extended release guanfacine
Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
CD25 treatment
Lidocaine/ ketamine
5-Fluorouracil
Ozanimod
Interferon beta-1b (Betaferon, BAY86-5046)
Methotrexate
Insulin
Miglustat
Dexmedetomidine
LDEPA
View Full List
CROs by country
Contract Research Organizations in Costa Rica
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gabon
Contract Research Organizations in Kuwait
Contract Research Organizations in Macedonia
Contract Research Organizations in Montenegro
Contract Research Organizations in Pakistan
Contract Research Organizations in Peru
Contract Research Organizations in Senegal
Contract Research Organizations in Serbia
Contract Research Organizations in Slovakia
Contract Research Organizations in Spain
Contract Research Organizations in Switzerland
CRO list by country
CROs in Portugal
W4Research
PPD
Fortrea
Blueclinical
VectorB2B
Alpha Bioresearch
IQVIA
SGS
Pivotal
All CROs in Portugal
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe